Suppr超能文献

原发性肿瘤中肝素酶对结直肠癌患者预后的影响。

Implication of Hepsin from Primary Tumor in the Prognosis of Colorectal Cancer Patients.

作者信息

Zaragoza-Huesca David, Nieto-Olivares Andrés, García-Molina Francisco, Ricote Guillermo, Montenegro Sofía, Sánchez-Cánovas Manuel, Garrido-Rodríguez Pedro, Peñas-Martínez Julia, Vicente Vicente, Martínez Francisco, Lozano María Luisa, Carmona-Bayonas Alberto, Martínez-Martínez Irene

机构信息

Centro Regional de Hemodonación, Department of Haematology and Medical Oncology, Hospital General Universitario Morales Meseguer, University of Murcia, IMIB-Arrixaca, 30100 Murcia, Spain.

Department of Pathology, Hospital General Universitario Morales Meseguer, 30008 Murcia, Spain.

出版信息

Cancers (Basel). 2022 Jun 24;14(13):3106. doi: 10.3390/cancers14133106.

Abstract

Hepsin is a type II transmembrane serine protease whose deregulation promotes tumor invasion by proteolysis of the pericellular components. In colorectal cancer, the implication of hepsin is unknown. Consequently, we aimed to study the correlations between hepsin expression and different clinical-histopathological variables in 169 patients with localized colorectal cancer and 118 with metastases. Tissue microarrays were produced from samples at diagnosis of primary tumors and stained with an anti-hepsin antibody. Hepsin expression was correlated with clinical-histopathological variables by using the chi-square and Kruskal−Wallis tests, Kaplan−Meier and Aalen−Johansen estimators, and Cox and Fine and Gray multivariate models. In localized cancer patients, high-intensity hepsin staining was associated with reduced 5-year disease-free survival (p-value = 0.16). Medium and high intensity of hepsin expression versus low expression was associated with an increased risk of metastatic relapse (hazard ratio 2.83, p-value = 0.035 and hazard ratio 3.30, p-value = 0.012, respectively), being a better prognostic factor than classic histological variables. Additionally, in patients with localized tumor, 5-year thrombosis cumulative incidence increased with the increment of hepsin expression (p-value = 0.038). Medium and high intensities of hepsin with respect to low intensity were associated with an increase in thrombotic risk (hazard ratio 7.71, p-value = 0.043 and hazard ratio 9.02, p-value = 0.028, respectively). This relationship was independent of previous tumor relapse (p-value = 0.036). Among metastatic patients, low hepsin expression was associated with a low degree of tumor differentiation (p-value < 0.001) and with major metastatic dissemination (p-value = 0.023). Hepsin is a potential thrombotic and metastatic biomarker in patients with localized colorectal cancer. In metastatic patients, hepsin behaves in a paradoxical way with respect to differentiation and invasion processes.

摘要

Hepsin是一种II型跨膜丝氨酸蛋白酶,其失调通过细胞周围成分的蛋白水解促进肿瘤侵袭。在结直肠癌中,hepsin的作用尚不清楚。因此,我们旨在研究169例局限性结直肠癌患者和118例转移患者中hepsin表达与不同临床组织病理学变量之间的相关性。从原发性肿瘤诊断时的样本中制作组织微阵列,并用抗hepsin抗体染色。通过卡方检验、Kruskal-Wallis检验、Kaplan-Meier和Aalen-Johansen估计器以及Cox和Fine及Gray多变量模型,将hepsin表达与临床组织病理学变量进行关联分析。在局限性癌症患者中,高强度hepsin染色与5年无病生存率降低相关(p值=0.16)。hepsin表达的中强度和高强度与低强度相比,转移复发风险增加(风险比分别为2.83,p值=0.035和风险比3.30,p值=0.012),是比经典组织学变量更好的预后因素。此外,在局限性肿瘤患者中,5年血栓累积发生率随hepsin表达增加而升高(p值=0.038)。hepsin的中强度和高强度与低强度相比,血栓形成风险增加(风险比分别为7.71,p值=0.043和风险比9.02,p值=0.028)。这种关系独立于先前的肿瘤复发(p值=0.036)。在转移患者中,低hepsin表达与肿瘤低分化程度相关(p值<0.001)和主要转移扩散相关(p值=0.023)。Hepsin是局限性结直肠癌患者潜在的血栓形成和转移生物标志物。在转移患者中,hepsin在分化和侵袭过程方面表现出矛盾的行为。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/be02/9264764/454afe4951c7/cancers-14-03106-g001.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验